Multiple preclinical studies on cell clines and murine models identified molecular targets for MPNST such as EGF and the mTOR signaling pathway with effective in vitro responses to targeted antagonization (Li et al. 2002; Johansson et al. 2008; Endo et al. 2013). This evidence concerns the gene EGF and malignant peripheral nerve sheath tumor.